𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson's disease in Japan

✍ Scribed by Ikuko Mizuta; Eiji Mizuta; Shunzou Yamasaki; Sadako Kuno; Minoru Yasuda; Chikako Tanaka

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
475 KB
Volume
15
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Catechol-O-methyltransferase inhibitors:
Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease
✍ Jasper Dingemanse πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 1 views

Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p

Interaction of polymorphisms in the gene
Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease
✍ Anna HΓ₯kansson; Lars Westberg; Staffan Nilsson; Silvia Buervenich; Andrea Carmin πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 68 KB

## Abstract The multifunctional cytokine interleukin‐6 (IL‐6) is involved in inflammatory processes in the central nervous system and increased levels of IL‐6 have been found in patients with Parkinson's disease (PD). It is known that estrogen inhibits the production of IL‐6, via action on estrogen